Pathology findings and clinical outcomes after risk reduction salpingo-oophorectomy in BRCA mutation carriers: a multicenter Spanish study.

CONCLUSION: The incidence of STIC after RRSO in BRCA mutation carriers is low (0.8%) and it presents an excellent oncological outcome. Patients after RRSO, however, run the risk to develop other types of cancer during follow-up and should be properly advised before the prophylactic surgery. PMID: 29623583 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29623583?dopt=Abstract

Source: Clinical Genitourinary Cancer - April 5, 2018 Category: Cancer & Oncology Authors: Minig L, Cabrera S, Oliver R, Couso A, Rubio MJ, Iacoponi S, Martin-Salamanca MB, Carballo-Rastrilla S, Cádenas-Rebollo JM, García-Garcia A, Gil-Ibáñez B, Juan-Fita MJ, Patrono MG Tags: Clin Transl Oncol Source Type: research